<DOC>
	<DOCNO>NCT02148120</DOCNO>
	<brief_summary>The aim study demonstrate non-inferiority term acute bronchodilator effect single dose CHF 1535 NEXThaler 200/6 µg single dose CHF 1535 NEXThaler 100/6 µg two dose level partially control uncontrolled asthmatic patient .</brief_summary>
	<brief_title>A Study Evaluate Acute Bronchodilator Effect CHF1535 NEXThaler</brief_title>
	<detailed_description />
	<mesh_term>Beclomethasone</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Bronchodilator Agents</mesh_term>
	<criteria>Patient 's write informed consent obtain prior studyrelated procedure . Male female age 18 65 year inclusive ; Evidence `` partially control '' `` uncontrolled '' asthma ; Medium daily dose previous inhaled corticosteroid ( ICS ) treatment ; FEV1 60 % 85 % predict normal value ; A document positive response reversibility test ; Nonsmokers exsmokers ; A cooperative attitude ability train proper use DPI . Pregnant lactate woman woman physiologically capable become pregnant willing use least one acceptable method contraception . Significant seasonal variation asthma occur expect occur study participation ; History near fatal asthma , brittle asthma , accident Emergency treatment hospitalisation asthma exacerbation Intensive Care Unit within 1 year screening ; Occurrence asthma exacerbation respiratory tract infection 4 week precede screening ; Diagnosis Chronic Obstructive Pulmonary Disease ; History cystic fibrosis , bronchiectasis alpha1 antitrypsin deficiency ; Diagnosis restrictive lung disease ; Patients treat oral parenteral corticosteroid previous 8 week ; Intolerance contraindication treatment beta2agonists and/or inhaled corticosteroid ; Allergy , sensitivity intolerance study drug excipients ; Patients receive investigational drug within last 8 week screen ; Patients take nonpermitted concomitant medication ; Subjects unlikely comply study protocol ; Any clinically relevant abnormal value physical find screening ; Significant medical history ; Abnormal clinically significant 12lead electrocardiogram ; Patients low compliance QVAR intake .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>